Follow
Peter Hartog
Peter Hartog
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors
HJ Sijben, WM van Oostveen, PBR Hartog, L Stucchi, A Rossignoli, ...
Scientific Reports 11 (1), 12290, 2021
52021
Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter Inhibitors
BJ Bongers, HJ Sijben, PBR Hartog, A Tarnovskiy, AP IJzerman, ...
Journal of Chemical Information and Modeling 63 (6), 1745-1755, 2023
22023
Label-free high-throughput screening assay for the identification of norepinephrine transporter inhibitors
HJ Sijben, WM van Oostveen, PBR Hartog, L Stucchi, A Rossignoli, ...
Sensing transport: label-free in itro assa s as an atTRACTi e alternati e …, 2022
2022
Brandon J. Bongers Abstract
BJ Bongers, P Hartog, HJ Sijben, LH Heitman, AP IJzerman, ...
The system can't perform the operation now. Try again later.
Articles 1–4